The Goldman Sachs Group Lowers Teladoc Health (NYSE:TDOC) Price Target to $10.00

Teladoc Health (NYSE:TDOC) had its target price reduced by research analysts at The Goldman Sachs Group from $13.00 to $10.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the health services provider’s stock. The Goldman Sachs Group’s price objective suggests a potential upside of 41.44% from the company’s current price.

A number of other research analysts have also commented on TDOC. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research report on Thursday. Bank of America dropped their price target on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating for the company in a research note on Friday, April 11th. Oppenheimer dropped their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Royal Bank of Canada boosted their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Piper Sandler dropped their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $9.81.

Teladoc Health Stock Performance

NYSE:TDOC opened at $7.07 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The firm has a market cap of $1.24 billion, a PE ratio of -1.23 and a beta of 1.73. The business has a 50 day moving average price of $8.02 and a 200-day moving average price of $9.49.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Equities research analysts predict that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.58% of the stock is owned by insiders.

Institutional Trading of Teladoc Health

Institutional investors and hedge funds have recently modified their holdings of the business. Golden State Wealth Management LLC boosted its position in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after buying an additional 1,690 shares during the last quarter. Versant Capital Management Inc boosted its holdings in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Teladoc Health during the 4th quarter valued at about $29,000. Lindbrook Capital LLC raised its holdings in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 1,612 shares during the last quarter. Finally, Sterling Capital Management LLC lifted its position in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after purchasing an additional 4,101 shares during the period. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.